Disease specific assessments (DSA) enable NTD program managers to measure programmatic impact and make important determinations about the continuation or discontinuation of treatment and other complementary interventions.
ENVISION aims to strengthen national program capacity to implement DSAs and to make data-driven decisions, while working to –
- Ensure that DSAs are well-coordinated and conducted according to WHO guidelines
- Increase coordination with the WHO Regional Program Review Groups and drug donation programs
- Address areas of improvements or failures noted in the DSA findings, investigating issues that may have contributed to the failure and supporting national programs to address
ENVISION prioritizes DSAs where USAID has previously supported MDA, with preference given to both LF and trachoma assessments, when necessary due to funding limitations.